$36.30
-0.60-1.63%
At close: Jun 10, 5:00 PM EST
$36.30
N/A
After Hours: 4:00 PM EST
Conmed Corp Stock Guidance
CNMDNYSE
Conmed (CNMD) last issued guidance on April 29, 2026 for fiscal year 2026. The company guided revenue in the range of $1.35B - $1.38B for the period.
Compared to prior guidance, Conmed maintained its revenue forecast from a prior range of $1.34B - $1.38B.
Conmed has issued 25 guidance updates between July 27, 2022 and April 29, 2026. During this period, the company raised its outlook 8 times and lowered it 8 times, providing investors with insight into management's evolving expectations.
Latest Guidance Date
Apr 29, 2026
Guidance Period
Full Year 2026
Revenue Guidance Range
$1.35B - $1.38B
Conmed Guidance History
Review all historical guidance issued by Conmed, including EPS and revenue forecasts across quarterly and annual periods.
Loading calendar...
FAQ
What is the most recent guidance for Conmed (CNMD)?
The most recent guidance for Conmed (CNMD) was reported on April 29, 2026 for the fiscal year 2026. Conmed forecasted revenue between $1.35B and $1.38B for the period.
What EPS range did Conmed (CNMD) guide for?
Conmed (CNMD) guided EPS in the range of $4.30 to $4.45 for the fiscal year 2026. The consensus analyst EPS estimate is $4.38.
What revenue range did Conmed (CNMD) guide for?
Conmed (CNMD) guided revenue in the range of $1.35B to $1.38B for the fiscal year 2026.
Did Conmed (CNMD) raise or lower guidance?
Conmed (CNMD) maintained its revenue guidance from a prior range of $1.34B - $1.38B to $1.35B - $1.38B for the fiscal year 2026.
When did Conmed (CNMD) last issue guidance?
Conmed (CNMD) last issued guidance on April 29, 2026 for the fiscal year 2026.
